Loading this company
Loading this company
Too wide to call. Our lenses land between ¥4,269.27 and ¥11,286.80, which is too broad to say where today’s price sits in it.
¥6,244.00JPY up +¥21.00 (+0.34%)
Quoted · Prices are delayed.
Nothing we can cite explains today’s move for this company.
Our range from 4 models, on today’s numbers
¥4,269.27–¥11,286.80
What the price needs: revenue growth of 10.1%/yr for 5 years (our model assumes 7.1%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Delayed price used by the model ¥6,254.00Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
¥6,665.81 across 16 analysts
The high and low of the analyst range is part of Pro. See plans
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. It operates in the Drug Manufacturers - Specialty & Generic industry (Healthcare sector), headquartered in Japan. The company employs roughly 47,029 people.
Prices are delayed. The feed does not say when these figures were taken.
No filings or corporate activity on file in the recent window.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.